دورية أكاديمية
Therapeutic Nanoparticles Harness Myeloid Cells for Brain Tumor-targeted Delivery and Immunomodulation.
| العنوان: | Therapeutic Nanoparticles Harness Myeloid Cells for Brain Tumor-targeted Delivery and Immunomodulation. |
|---|---|
| المؤلفون: | Ellingwood A; Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Wan H; Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lee-Chang C; Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lesniak MS; Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Zhang P; Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. |
| المصدر: | Material matters : chemistry driving performance [Mat Matters (Milwaukee)] 2022; Vol. 17 (2), pp. 29-36. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Aldrich Chemical Co Country of Publication: United States NLM ID: 9918540384206676 Publication Model: Print Cited Medium: Internet ISSN: 1933-964X (Electronic) Linking ISSN: 19339631 NLM ISO Abbreviation: Mat Matters (Milwaukee) Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Milwaukee, WI : Aldrich Chemical Co., ©2006- |
| References: | Nat Rev Drug Discov. 2021 Feb;20(2):101-124. (PMID: 33277608) Biomaterials. 2018 Oct;181:35-52. (PMID: 30071380) Adv Mater. 2018 Dec;30(50):e1805557. (PMID: 30368972) Nat Nanotechnol. 2017 Jul;12(7):692-700. (PMID: 28650441) Cancer Cell. 2017 Mar 13;31(3):326-341. (PMID: 28292436) Cell. 2020 Jun 25;181(7):1643-1660.e17. (PMID: 32470396) Immunity. 2018 Apr 17;48(4):812-830.e14. (PMID: 29628290) Adv Mater. 2021 Mar;33(9):e2006116. (PMID: 33501743) Nanomedicine. 2019 Feb;16:126-137. (PMID: 30553919) Clin Cancer Res. 2007 Mar 15;13(6):1663-74. (PMID: 17363519) Nat Commun. 2019 Sep 3;10(1):3974. (PMID: 31481662) Cell. 2020 Jun 25;181(7):1626-1642.e20. (PMID: 32470397) Front Immunol. 2020 Sep 16;11:1749. (PMID: 33042107) J Immunother Cancer. 2020 Aug;8(2):. (PMID: 32817393) Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23714-23723. (PMID: 31712430) Nat Nanotechnol. 2021 May;16(5):538-548. (PMID: 33526838) Nat Rev Genet. 2022 May;23(5):265-280. (PMID: 34983972) Adv Funct Mater. 2015 Jul 15;25(27):4183-4194. (PMID: 27340392) Drug Deliv. 2018 Nov;25(1):1922-1931. (PMID: 30465444) |
| معلومات مُعتمدة: | R01 CA266487 United States CA NCI NIH HHS; R37 CA266487 United States CA NCI NIH HHS; R01 NS115955 United States NS NINDS NIH HHS; R35 CA197725 United States CA NCI NIH HHS; P50 CA221747 United States CA NCI NIH HHS |
| تواريخ الأحداث: | Date Created: 20230215 Latest Revision: 20230421 |
| رمز التحديث: | 20230421 |
| مُعرف محوري في PubMed: | PMC9924093 |
| PMID: | 36789150 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1933-964X |
|---|